PC and cancer: Therefore, as a BBB penetrant PC-3 activator, PAC-1 is uniquely positioned as a therapeutic that can circumvent the wide range of upstream apoptotic evasion strategies adopted by cancer cells; and molecularly, it functions via direct chelation of labile cellular zinc with consequent caspase-3 activation and induction of apoptotic cell death (35, 42).